Dissecting regional variability in Pyrazinamide prescribing practices for tuberculosis treatment in Japan
Open Access
- 22 November 2024
- journal article
- research article
- Published by Elsevier in Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
- Vol. 37, 100497
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Effect of desire for pregnancy on decisions to escalate treatment in multiple sclerosis care: Differences between MS specialists and non-MS specialistsMultiple Sclerosis and Related Disorders, 2022
- Pulmonary Tuberculosis in Older Adults: Increased Mortality Related to Tuberculosis Within Two Months of Treatment InitiationDrugs & Aging, 2021
- Safety of pyrazinamide-including regimen in late elderly patients with pulmonary tuberculosis: A prospective randomized open-label studyJournal of Infection and Chemotherapy, 2019
- TuberculosisThe Lancet, 2019
- User's guide to correlation coefficientsTurkish Journal of Emergency Medicine, 2018
- Daily vs Intermittent Antituberculosis Therapy for Pulmonary Tuberculosis in Patients With HIVJAMA Internal Medicine, 2018
- Emergence of drug resistance in patients with tuberculosis cared for by the Indian health-care system: a dynamic modelling studyThe Lancet Public Health, 2017
- Construction of a mathematical model for tuberculosis transmission in highly endemic regions of the Asia-pacificJournal of Theoretical Biology, 2014
- Japanese universal health coverage: evolution, achievements, and challengesThe Lancet, 2011
- Why does specialist treatment of breast cancer improve survival? The role of surgical managementBritish Journal of Cancer, 2004